Scientists at Rutgers University–Newark have developed a first-of-its-kind RNA-based nanotechnology that assembles itself ...

On Wednesday, AbbVie Inc (NYSE:ABBV) and Xilio Therapeutics, Inc. (NASDAQ:XLO) announced a collaboration and option-to-license agreement to develop novel tumor-activated, antibody-based ...

Researchers at NYU Abu Dhabi have developed a new light-based nanotechnology that could improve how certain cancers are ...

Researchers developed light-responsive nanoparticles that selectively enter tumors and convert near-infrared light into heat.

TYLER, Texas (KETK) — The National Institutes of Health has issued UT Tyler a $441,000 grant for funding to develop cancer-targeting nanotechnology. “At UT Tyler, we’re committed to advancing research ...

Researchers developed an iron-based nanomaterial that exploited tumor acidity and hydrogen peroxide to generate two reactive ...

Oncotelic Therapeutics Inc.'s (OTCQB: OTLC) Sapu Nano joint venture is making progress with Sapu003, its intravenous Deciparticle formulation of everolimus, the powerful drug to fight cancer and ...

In a recent article published in Signal Transduction and Targeted Therapy, researchers introduced polymer-based nano-PROteolysis Targeting Chimeras (PROTACs) to address ongoing challenges in targeted ...

University of Queensland researchers are designing nanotechnology they believe could improve how we treat the most aggressive form of breast cancer. Professor Chengzhong (Michael) Yu and his team are ...

Scientists describe how nanotechnology principles developed to deliver toxic drugs to cancer cells could help produce more environmentally-friendly pesticides and fungicides. (Nanowerk News) Cancer ...